An experimental assessment of toxic potential of nanoparticle preparation of heavy metals in streptozotocin induced diabetes

Experimental and Toxicologic Pathology

Volumn 65, Issue 7-8, 2013, Pages 1127-1135

  Gandhi, Sonia ^a   Srinivasan, B P ^a   Akarte, Atul Sureshrao ^a  

^a DELHI INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

Author keywords

Apoptosis; Autometallography; Diabetic nephropathy; Mercury; Metallothionein; Nephrin

Indexed keywords

ADIPONECTIN; ALBUMIN; CREATININE; CYSTATIN C; ERYTHROPOIETIN; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 4; GOLD; HEAVY METAL; INSULIN; IRON; LEAD; MERCURY; NANOPARTICLE; NEPHRIN; NITRIC OXIDE; SILVER; TIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; EXPERIMENTAL STUDY; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; IMMUNE RESPONSE; INSULIN BLOOD LEVEL; KIDNEY PARENCHYMA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARTICLE SIZE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; TOXICITY TESTING;

RATTUS NORVEGICUS;

APOPTOSIS; AUTOMETALLOGRAPHY; DIABETIC NEPHROPATHY; MERCURY; METALLOTHIONEIN; NEPHRIN;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DNA FRAGMENTATION; GLOMERULAR FILTRATION RATE; IMMUNOHISTOCHEMISTRY; INSULIN; KIDNEY; MEDICINE, AYURVEDIC; METAL NANOPARTICLES; METALS, HEAVY; RATS; RATS, WISTAR;

EID: 84885855265     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2013.05.004     Document Type: Article

References (43)

1. Alkilany A.M., Murphy C.J. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?. Journal of Nanoparticle Research 2010, 12:2313-2333.
2. Allison A.E. Proteinuria and interstitial injury. Nephrology, Dialysis, Transplantation 2004, 19:277-281.
3. Andrew J.K. Diabetes 2000, 1. Churchill Living Stone, New York.
4. Arulmozhi D.K., Veeranjaneyulu A., Bodhankar S.L. Neonatal streptozotocin induced rat model of type 2 diabetes mellitus: a glance. Indian Journal of Pharmacology 2004, 38(4):217-221.
5. Bigazzi P. Lessons from animal models: the scope of mercury induced autoimmunity. Clinical Immunology and Immunopathology 1992, 65:81-84.
6. David J. Evaluation of renal function. Nephrology 2005, 10:133-176.
7. Davis B.J., Johnston C.I., Burrell L.M., Burns W.C., Kubota E., Cao Z., et al. Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy. Diabetologia 2003, 46(7):961-971.
8. Filler G., Witt I., Priem F., Ehrich J.H.H., Jung K. Are cystatin C and b2-microglobulin better markers than serum creatinine for prediction of a normal glomerular filtration rate in pediatric subjects?. Clinical Chemistry 1997, 43(6):1077-1078.
9. Finkelstein A.E., Walz D.T., Batista V., Mizraji M., Roisman F., Misher A. Auranofin: new oral gold compound for treatment of rheumatoid-arthriritis. Annals of the Rheumatic Diseases 1976, 35:251-257. 10.1136/ard.35.3.251.
10. Foley R.N., Collins A.J. End stage renal disease in United states: an update from United States Renal Data System. J Am Soc Nephrol. 2007, 18(10):2644-2648.
11. Fuhr B.J., Rabenstein D.L. Nuclear magnetic resonance studies of solution chemistry of metal-complexes: binding of cadmium, zinc, lead and mercury by glutathione. Journal of the American Chemical Society 1973, 95:6944-6950.
12. Grieve K.A., Balazs N., Comper W.D. Protein fragments in urine have been considerably underestimated by various protein assays. Clinical Chemistry 2001, 47:1717-1719.
13. Gurunathan S., Lee K.J., Kalimuthu K., Sheikpranbabu S., Vaidyanathan R., Eom S.H. Antiangiogenic properties of silver nanoparticles. Biomaterials 2008, 30:6341-6350.
14. Hultman P., Enestrom S. Dose response studies in murine mercury-induced autoimmunity and immune complex disease. Toxicology and Applied Pharmacology 1992, 113:199-208.
15. Janet B., McGill, David S.H. Anemia and the role of erythropoietin in diabetes. Journal of Diabetes and its Complications 2006, 20:262-272.
16. Kapoor R.C. Some observations on the metal-based preparations in the Indian System of Medicine. Indian Journal of Traditional Knowledge 2010, 9(3):562-575.
17. Kaysen G., Don B.R. Serum albumin concentration and chronic kidney disease. US Nephrology 2010, 5(1):20-27.
18. Kelly D.J., Zhang Y., Moe G., Naik G., Gilbert R.E. Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats. Diabetologia 2008, 50:2398-2404.
19. Kelly D.J., Wilkinson-Berka J.L., Allen T.J., Cooper M.E., Skinner S.L. A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR). Kidney International 1998, 154:343-352.
20. Kurien B.T., Everds N.E., Scofield R.H. Experimental animal urine collection: a review. Laboratory Animals 2004, 38:333-361.
21. ManiKanth S.B., Kalishwaralal K., Sriram M., Pandian S.B.R.K., Youn H., Eom S.H., et al. Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. Journal of Nanobiotechnology 2010, 8:16.
22. María L., Villanueva P., Jesús P., Araceli R., Felipe C., Isabel V. Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models. Endocrine 2001, 15(2):241-248.
23. Matsuno T., Sasaki H., Nakagawa K. Fas antigen expression and apoptosis in kidney allografts. Transplantation Proceedings 1997, 29:177-178.
24. Mauer S.M., Chavers B.M. A comparison of kidney disease in type I and type II diabetes. Advances in Experimental Medicine and Biology 1985, 189:299-303.
25. Naggar E.M. Antidiabetic effect of Cleome droserifolia aerial parts: lipid peroxidation-induced oxidative stress in diabetic rats. Acta Veterinaria Brno 2005, 74:347-352.
26. Nakamaki S., Satoh H., Kudoh A., Hayashi Y., Hirai H., Watanabe T. Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats. Experimental Biology and Medicine (Maywood, NJ) 2011, 236(5):614-620.
27. Nayagam A.A.J., Kumaraswamy A., Pemaiah B. Antidiabetic activity of a traditional Ayurvedic formulation - JASAD BHASMA. Journal of Pharmacy Research 2010, 3(12):2916-2918.
28. Pamphlett R., Kum-Jew S. Mercury vapor uptake into the nervous system of developing mice. Neurotoxicology and Teratology 2001, 23:191-196.
29. Pandit S., Biswas T.K., Debnath P.K., Saha A.V., Chowdhury U., Shaw B.P., et al. Chemical and pharmacological evaluation of different Ayurvedic preparations of iron. Journal of Ethnopharmacology 1999, 65:149-156.
30. Patel NG. In: Steiner RP, editor. Folk medicine: the art and the science, vol. 41. Washington: American Chemical Society; 1986. Shastry KN, Rasataringini, English translation of original in Sanskrit, In: Sadananda, editor. Motilal Banarsidas, Varanasi; 1979.
31. Perrone R.D., Madias N.E., Levey A.S. Serum creatine as an index of renal function. New insights into an old concept. Clinical Chemistry 1992, 38:1933.
32. Rodier P.M., Kates B., Simons R. Mercury localization in mouse kidney over time: autoradiography versus silver staining. Toxicology and Applied Pharmacology 1988, 92(2):235-245.
33. Roman-Franco A.A., Turiello M., Albini B., Ossi E., Milgrom F., Andres G.A. Anti-basement membrane antibodies and antigen-antibody complexes in rabbits injected with mercuric chloride. Clinical Immunology and Immunopathology 1978, 9:464-481.
34. Ruegg C.E., Gandolfi A.J., Nagle R.B., Brendel K. Differential patterns of injury to the proximal tubule of renal cortical slices following in vitro exposure to mercuric chloride, potassium dichromate, or hypoxic conditions. Toxicology and Applied Pharmacology 1987, 90:261-271.
35. Singh S.K., Chaudhary A., Rai D.K., Rai S.B. Preparation and characterization of a mercury based Indian traditional drug - Ras Sindoor. Indian Journal of Traditional Knowledge 2009, 8(2):346-351.
36. Sonta T., Inoguchi T., Matsumoto S., Yasukawa K., Inuo M., Tsubouchi H., et al. In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker. Biochemical and Biophysical Research Communications 2005, 330:415-422.
37. Tohyama C., Nishimura H., Nishimura N. Immunohistochemical localization of metallothionein in the liver and kidney of cadmium- or zinc- treated rats. Acta Histochemica et Cytochemica 1988, 21:91.
38. Torben H. Genetics of type 2 diabetes. Current Science 2002, 83:1477-1482.
39. Vinodhini R., Narayanan M. Heavy metal induced histopathological alterations in selected organs of the Cyprinus carpio L. (common carp). International Journal of Environmental Research 2009, 3(1):95-100.
40. Weir G.C., Clore E.E., Zma-Chinsky C.J., Bonnier-weir S. Islet secretion in new experimental model of non-insulin dependent diabetes. Diabetes/Metabolism Reviews 1981, 30:590-594.
41. Yoshihiko H., Takuya I., Kaoru Y., Nobuo K. Effects of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on hyperglycemia in streptozotocin-induced diabetic rats. Biological and Pharmaceutical Bulletin 2007, 30(5):1015-1020.
42. Zalups R.K., Robinson M.K., Barfuss D.W. Factors affecting inorganic mercury transport and toxicity in the isolated perfused tubule. Journal of the American Society of Nephrology 1991, 2:866-878.
43. Ziemba S.E., Mattingly R.R., McCabe M.J., Rosenspire A.J. Inorganic mercury inhibits the activation of LAT in T-cell receptor-mediated signal transduction. Toxicological Sciences 2006, 89(1):145-153.